- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02412124
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
Quality of Life Outcomes From a Peer-to-Peer Support Program for Women With Gynecologic Cancer
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
PRIMARY OBJECTIVES:
I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients with gynecologic cancer at City of Hope (COH). Address the following descriptive research questions: were patients, mentors, and patients' family caregivers satisfied with the timing, format, and content of the program? Did the program benefit patients, mentors, and patients' family caregivers?
OUTLINE:
Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.
After completion of study, patients are followed up at 6 and 12 months.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
Duarte, California, États-Unis, 91010
- City of Hope Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- PATIENT PARTICIPANTS
- Patients with newly diagnosed or recurrent gynecologic cancer (ovarian, uterine, cervical, vaginal, vulvar) actively undergoing treatment (chemotherapy, surgery, or radiation therapy) at COH (including Duarte and South Pasadena campuses)
- English-speaking patients
- PEER MENTORS
- Peer mentors will be past gynecologic cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
- Over age 18
- PEER MENTORS: English-speaking patients
- This study is open to patients of all races and ethnicities
Exclusion Criteria:
- PEER MENTORS:
- Major psychiatric disease
- Currently undergoing treatment for active gynecologic cancer
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Supportive care (W2W program)
Patients participate in the W2W program for which they are matched with a trained mentor and followed throughout treatment by phone, email, and/or in person.
|
Complete W2W mentoring program
Autres noms:
Complete the FACT-G
Autres noms:
Complete the W2W Patient Survey
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in quality of life benefits for patients, as assessed by the FACT-G
Délai: Baseline to up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.
Written comments from all open ended questions analyzed using content analysis methods.
|
Baseline to up to 12 months
|
Satisfaction of patients with the timing, content, and format of the program, as assessed by the W2W Patient Survey
Délai: Up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
|
Up to 12 months
|
Satisfaction of mentors with the timing, content, and format of the program, as assessed by the W2W Volunteer/Mentor Survey
Délai: Up to 12 months
|
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
|
Up to 12 months
|
Satisfaction of patients' family caregivers with the timing, content, and format of the program
Délai: Up to 12 months
|
Changes from baseline will be tested using paired t-tests.
Descriptive statistics on participants' satisfaction with the timing, content, and format of the intervention will be presented through summary statistics of data from the satisfaction tools.
|
Up to 12 months
|
Benefits for patients' family caregivers after participating in the program, as assessed by the Modified Caregiver Strain Index
Délai: Up to 12 months
|
Data will be summarized using descriptive statistics, including means for normally distributed continuous data, medians for non-normally distributed continuous data or proportions for categorical data.
Established instruments will be scored according to standard instructions, and appropriate descriptive statistics computed.
Written comments from all open ended questions analyzed using content analysis methods.
|
Up to 12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Thanh Dellinger, MD, City of Hope Medical Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 14359 (Autre identifiant: City of Hope Medical Center)
- NCI-2015-00467 (Identificateur de registre: CTRP (Clinical Trial Reporting Program))
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Carcinome du col de l'utérus
-
Imperial College Healthcare NHS TrustImperial College London; The Wellington Hospital, LondonComplété
-
Duke UniversityNational Cancer Institute (NCI); Jacobi Medical CenterComplété
-
Michigan State UniversityAmerican Osteopathic AssociationComplété
-
Duke UniversityUniversity of ArkansasComplété
-
New York Institute of TechnologyComplété
-
Michigan State UniversityComplété
-
NuVasiveActif, ne recrute pasTrouble discal dégénératif cervicalÉtats-Unis
-
Goethe UniversityComplétéCinématique | Fiabilité | CervicalAllemagne
-
Xin Jiang, MDInconnueBloc du plexus cervical superficielChine
-
National Cancer Institute (NCI)ComplétéPoumon | Sein | Ovaire | Cervical | RénalÉtats-Unis
Essais cliniques sur Supportive Care
-
Silke Wiegand-Grefe, Prof. Dr.Charite University, Berlin, Germany; Hannover Medical School; University Hospital... et autres collaborateursActif, ne recrute pasMaladies raresAllemagne
-
Medical University InnsbruckBarmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... et autres collaborateursComplétéAccident vasculaire cérébral | Attaque ischémique, transitoire | L'analyse coûts-avantages | Prévention secondaire | Gestion des maladiesL'Autriche
-
Chung Shan Medical UniversityComplétéSoignant | Patient d'AVCTaïwan
-
Johnson & Johnson Vision Care, Inc.ComplétéAcuité visuelle, biomicroscopie à la lampe à fente (évaluation de la coloration cornéenne)États-Unis
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Ministry of Health...Complété
-
University Hospital, AngersComplétéDouleur thoraciqueFrance, Belgique
-
Emory UniversityRetirement Research FoundationComplétéSyndrome de stress du soignantÉtats-Unis
-
Weill Medical College of Cornell UniversityCornell UniversityPas encore de recrutementFardeau des soignantsÉtats-Unis
-
University of StirlingComplétéVieillissement | Vieillir en bonne santé | Personnes âgées | VieilliRoyaume-Uni
-
University Health Network, TorontoRecrutementLymphome | Troubles lymphoprolifératifs | Cancer du sein stade I | Cancer du sein stade II | Cancer colorectal stade II | Cancer colorectal stade III | Cancer du sein stade III | Cancer colorectal stade I | Cancer de la tête et du cou stade III | Cancer du sein, stade 0 | Cancer de la tête et du cou stade... et d'autres conditionsCanada